首页> 外文期刊>Nature >The mutational constraint spectrum quantified from variation in 141,456 humans
【24h】

The mutational constraint spectrum quantified from variation in 141,456 humans

机译:从141,456人中的变化量化的突变约束谱

获取原文
获取原文并翻译 | 示例
       

摘要

Abstract Genetic variants that inactivate protein-coding genes are a powerful source of information about the phenotypic consequences of gene disruption: genes that are crucial for the function of an organism will be depleted of such variants in natural populations, whereas non-essential genes will tolerate their accumulation. However, predicted loss-of-function variants are enriched for annotation errors, and tend to be found at extremely low frequencies, so their analysis requires careful variant annotation and very large sample sizes1. Here we describe the aggregation of 125,748 exomes and 15,708 genomes from human sequencing studies into the Genome Aggregation Database (gnomAD). We identify 443,769 high-confidence predicted loss-of-function variants in this cohort after filtering for artefacts caused by sequencing and annotation errors. Using an improved model of human mutation rates, we classify human protein-coding genes along a spectrum that represents tolerance to inactivation, validate this classification using data from model organisms and engineered human cells, and show that it can be used to improve the power of gene discovery for both common and rare diseases.
机译:摘要灭活蛋白质编码基因的遗传变异是关于基因破坏的表型后果的强大信息来源:对生物体功能至关重要的基因将耗尽天然群体的这种变体,而非必需基因将耐受他们的积累。然而,预测函数损失变体富集用于注释误差,并且倾向于以极低的频率发现,因此它们的分析需要仔细的变体注释和非常大的样本尺寸。在这里,我们描述了125,748个Exomes和15,708个基因组的聚集在人体测序研究中进入基因组聚集数据库(Gnomad)。在过滤由测序和注释误差引起的人造象中过滤后,我们识别443,769的高信心预测在该队列中的函数丧失变体。利用人体突变率的改进模型,我们将人蛋白编码基因沿着代表灭活的差异,使用来自模型生物和工程化的人体细胞的数据验证该分类,并表明它可用于提高力量常见和罕见疾病的基因发现。

著录项

  • 来源
    《Nature》 |2020年第7809期|434-443|共10页
  • 作者单位

    Broad Institute of MIT and Harvard|Massachusetts General Hospital;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Harvard Medical School;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Harvard Medical School;

    Broad Institute of MIT and Harvard|Harvard Medical School|Massachusetts General Hospital;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Institute for Molecular Medicine Finland;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital;

    Queen Mary University of London and Barts Health NHS Trust;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Harvard Medical School;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Imperial College London|Royal Brompton &

    Harefield Hospitals NHS Trust;

    University of Washington;

    Wellcome Genome Campus;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Vertex Pharmaceuticals Inc;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Boston Children’s Hospital|Harvard Medical School;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Yale School of Medicine;

    Broad Institute of MIT and Harvard|Imperial College London|Royal Brompton &

    Harefield Hospitals NHS Trust;

    Massachusetts General Hospital|Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard|Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Harvard Medical School;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Institute for Molecular Medicine Finland|Broad Institute of MIT and Harvard;

    Broad Institute of MIT and Harvard|Massachusetts General Hospital|Garvan Institute of Medical Research and UNSW Sydney|Murdoch Children’s Research Institute;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 22:15:26

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号